Related Experiment Video
Updated: Jan 9, 2026

08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
4.3K
Transcatheter Edge-to-Edge Repair of Tricuspid Regurgitation With TriClip: A Step-by-Step Guide
Georgios E Papadopoulos1, Ilias Ninios1, Sotirios Evangelou1
1Cardiology Department, Interbalkan Medical Center, 57001 Thessaloniki, Greece.
Reviews in Cardiovascular Medicine
|December 8, 2025
Summary
Tricuspid regurgitation (TR) is a serious condition undertreated due to high surgical risk. Tricuspid transcatheter edge-to-edge repair (T-TEER) offers a minimally invasive solution for high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Devices
Background:
- Tricuspid regurgitation (TR) is increasingly recognized as a progressive disease linked to significant morbidity and mortality.
- Current treatment limitations include lack of effective medical therapies and high surgical risks.
- Tricuspid transcatheter edge-to-edge repair (T-TEER) presents a minimally invasive option for symptomatic severe TR in high-risk patients.
Purpose of the Study:
- To provide a comprehensive review of the TriClip system for T-TEER.
- To outline a step-by-step approach to TriClip implantation, including patient selection, imaging, and techniques.
- To discuss intra-procedural challenges, troubleshooting, and post-procedural management.
Main Methods:
- Review of anatomical and pathophysiological factors relevant to T-TEER.
- Detailed description of TriClip implantation procedures, emphasizing transesophageal echocardiography guidance.
- Analysis of intra-procedural and post-procedural management strategies.
- Comparative analysis of TriClip and PASCAL systems.
- Exploration of combined mitral and tricuspid TEER.
Main Results:
- Evidence from trials and registries supports the safety, feasibility, and durability of TriClip-based T-TEER.
- Transesophageal echocardiography is critical for successful device guidance and procedural confirmation.
- Combined mitral and tricuspid TEER shows early promise for safety and efficacy.
Conclusions:
- T-TEER with the TriClip system is a viable, minimally invasive alternative for high-risk patients with severe TR.
- The procedure requires careful patient selection, meticulous technique, and comprehensive post-procedural care.
- T-TEER is poised to become a key treatment modality for functional TR in high-risk populations as technology and experience advance.
Related Concept Videos
Mitral Regurgitation III: Medical Management
257
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
257
Cardiac Catheterization I: Pre-Procedure Overview
997
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
997
Mitral Stenosis III: Medical Management
223
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Aortic Regurgitation III: Medical Management
375
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
375

